Clinical utilization of Chimeric Antigen Receptors T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL) - an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT).
Document Type
Journal Article
Publication Date
12-18-2018
Journal
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
DOI
10.1016/j.bbmt.2018.12.068
APA Citation
Kansagra, A., Frey, N., Bar, M., Laetsch, T., Carpenter, P., Savani, B., Heslop, H., Bollard, C., Komanduri, K., Gastineau, D., Chabannon, C., Perales, M., Hudecek, M., Aljurf, M., Andritsos, L., Barrett, J., Bachanova, V., Bonini, C., Ghobadi, A., Gill, S., Hill, J., Kenderian, S., Kebriaei, P., Nagler, A., Maloney, D., Liu, H., Shah, N., Kharfan-Dabaja, M., Shpall, E., Mufti, G., Johnston, L., Jacoby, E., Bazarbachi, A., DiPersio, J., Pavletic, S., Porter, D., Grupp, S., Sadelain, M., Litzow, M., Mohty, M., & Hashmi, S. (2018). Clinical utilization of Chimeric Antigen Receptors T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL) - an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT).. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, (). http://dx.doi.org/10.1016/j.bbmt.2018.12.068
Peer Reviewed
1
Comments
Epub ahead of print